首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

DIABETES & METABOLISM
ISSN：1262-3636

DIABETES & METABOLISM

DIABETES METAB
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：较慢,6-12周
新锐分区：医学2区
年发文量：54
影响因子：4.7
JCR分区：Q1

基本信息

拥有国际读者的高质量科学期刊SFD的官方出版物《糖尿病与代谢》发表了领先团队的高质量论文，在医院和研究单位之间形成了密切的联系。Diabetes & Metabolism以英语出版，并在所有主要数据库中被索引，其影响因素不断进步。Diabetes & Metabolism包含原创文章，简短报告和综合评论。后者是由国际公认的专家精心编辑的更新，以帮助临床医生和研究人员了解糖尿病领域的最新发展。
1262-3636SCIE/Scopus收录
4.7
点击查看最新影响趋势>
5.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：ENDOCRINOLOGY & METABOLISM
SCIE
Q1
39/193
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：ENDOCRINOLOGY & METABOLISM
SCIE
Q1
32/193
79
54
点击查看年发文量趋势图>
7%较易较慢,6-12周-医学-内分泌学与代谢
2.1%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
88.89%15.98%1.72%
CiteScore：11.00
SJR：1.648
SNIP：1.159
学科类别分区排名百分位
大类：Medicine
小类：Endocrinology, Diabetes and Metabolism
Q1
23 / 247
大类：Medicine
小类：Endocrinology
Q1
13 / 130
大类：Medicine
小类：Internal Medicine
Q1
17 / 171

期刊高被引文献

Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.008
Burden of diabetes, hyperglycaemia in China from to 2016: Findings from the 1990 to 2016, global burden of disease study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.008
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.101117
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.10.003
Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.05.010
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.12.001
Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.02.006
Complement activation in patients with diabetic nephropathy.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.04.001
Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.06.006
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.006
Metabolomics signatures associated with an oral glucose challenge in pregnant women.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.004
Links between aldosterone excess and metabolic complications: A comprehensive review.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.003
Association of C-peptide with diabetic vascular complications in type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.04.004
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.09.002
Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: Retrospective cohort studies.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.007
Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.02.002
Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.001
Obstructive sleep apnoea syndrome in patients living with diabetes: Which patients should be screened?
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.006
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.004
A systematic literature review of observational studies of the bidirectional association between metabolic syndrome and migraine.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.12.004
Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazide.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.06.007
Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.04.006
Association between BMI and risk of severe hypoglycaemia in type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.03.006
The gut microbiota and diabetic cardiomyopathy in humans.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.003
Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.05.008
The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.001
Evacuation is a risk factor for diabetes development among evacuees of the Great East Japan earthquake: A 4-year follow-up of the Fukushima Health Management Survey.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.09.005
Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.08.010
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.004
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.003
Metformin is associated with a lower risk of non-Hodgkin lymphoma in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.05.002
Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.12.003
High expression of CPT1b in skeletal muscle in metabolically healthy older subjects.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.018
Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-α using 1H MR spectroscopy and MRI.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.01.005
Diabetes-related distress is reduced in people with type 1, but not type 2 diabetes after participating in a diabetes treatment and teaching programme.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.11.008
Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.003
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.12.002
Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.10.005
Alirocumab efficacy and safety by body mass index: a pooled analysis from 10 Phase 3 ODYSSEY trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.101120
Serum fructosamine predicts macrosomia in well-controlled hyperglycaemic pregnant women: an observational cross-sectional study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.07.003
Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.08.001
Insulin secretion in response to high extracellular calcium is not a pathognomonic feature of insulinoma cells.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.008
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.005
Metabolic And Psychological Effects Of Short-Term Increased Consumption Of Less-Processed Foods In Daily Diets: A Pilot Study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.07.002
SGLT2 Inhibition Increases Serum Copeptin in Young Adults with Type 1 Diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.11.006
Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.04.007
Low normal fasting glucose and risk of accidental death in Korean adults: A prospective cohort study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2018.01.005
The association between handgrip strength and sleep duration in Japanese patients with type 2 diabetes.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.005
Heart rate variability in fetuses of type 1 diabetes pregnancies.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2017.07.002
Competing risk analysis on visit-to-visit glucose variations and risk of depression: The Taiwan Diabetes Study.
来源期刊：Diabetes & metabolismDOI：10.1016/j.diabet.2019.08.003

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区
否
否